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Message from the Director

Volume 2: Dementia Caregiving Research at CARAH

Helping Caregivers to COPE
When Deb Lacktman promised her dying
father that she would care for her mother,
Margaret Rimato, after he passed, she wasn’t
prepared for the challenges to come. Shortly
after he passed, Margaret became increasingly
forgetful and delusional. Deb attributed her
mother’s memory loss to the stress of losing
her husband. With time, however, Margaret’s
condition worsened and she was diagnosed
with Alzheimer’s disease.
As the primary caregiver of a parent
with Alzheimer’s, Deb dealt with various
complications beyond the memory loss. Her
mother continually roamed the house in the
middle of the night, for no apparent reason.
It turned out that her irregular sleep patterns
were due to arthritis in her arm as well as
painful kidney infections. Deb had a hard
time gauging her mother’s pain because her
mother couldn’t articulate it.
“I carried a lot of guilt since I didn’t know
about Mom’s pain,” admits Deb. “She can’t
describe her current pain, so I’ve learned to
look for non-verbal clues.”
Awareness of non-verbal clues of pain was just
one of the techniques Deb learned through
her participation in Project COPE. Project
COPE is a study designed to help caregivers
learn new ways to manage the challenges of
caregiving and is conducted by the Center
for Applied Research on Aging and Health
(CARAH) at Thomas Jefferson University.

Deb Lacktman with her mother Margaret.

Project COPE is funded by the Pennsylvania
State Department of Health Tobacco grant
funds as part of the Pennsylvania Center of
Excellence in Alzheimer’s disease awarded
to the Farber Institute for Neurosciences at
Jefferson.
Deb was drawn to Project COPE because it
focused on both the needs of caregivers and
the quality of life of patients. Dr. Laura N.
Gitlin, the principal investigator of the study,
explains, “Project COPE builds on over 15
years of research conducted by CARAH on
family caregiving and dementia care. Taken
as a whole, these studies show that there are
various non-pharmacological approaches that
families can use to effectively manage this
devastating disease and enhance the well-being
of their family member with dementia
and themselves.”
Tracey Vause-Earland, clinical coordinator and
one of the occupational therapy interventionists
at CARAH, worked directly with Deb in her
Continued on page 2
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Welcome to the second
issue of CenterPieces,
the newsletter of the
Center for Applied
Research on Aging and
Health. We dedicate
this issue to the topic
Dr. Laura Gitlin,
of dementia and family Director of CARAH
caregiving, a critical
public health issue.
There are 26 million
individuals with dementia worldwide,
and approximately 5 million individuals
with the diagnosis in the US. This
number may exceed 16 million in 2050.
For the past 15 years, CARAH has
been in the forefront of developing
and testing innovative approaches to
supporting families in their heroic care
efforts and enhancing the quality of
life of affected individuals. CARAH’s
current research focus is on testing nonpharmacological approaches to managing
one of the most complex aspects of
the disease, disruptive behaviors.
We remain deeply indebted to the
many families who have shared their
stories and knowledge with us so that
we may learn from their experiences
as we work together to identify the best
approaches to manage the disease. In
this issue, you will learn about research
studies conducted at Jefferson and
the important role of clinical trials
in helping to identify effective
dementia treatments.
If you are a caregiver, know someone
who is caregiving, or a health provider
working with families dealing with
dementia, we invite you to contact
us to learn more about participating
in our studies. Call us at 215-5032897 or visit our web site at
www.jefferson.edu/jchp/carah.

Speaking With Barry Rovner, MD
Q: What Alzheimer’s related studies are you
involved in currently at the Farber Institute
for Neurosciences?
Dr. Rovner: We are evaluating three exciting
new disease-modifying drug treatments that
may slow down the course of Alzheimer’s
disease. I am also a Principal Investigator
of Jefferson’s Center for Excellence in
Neurodegenerative Diseases funded by
the Pennsylvania
Department of Health
Tobacco Settlement
grant. We are testing
innovative screening
methods to identify
dementia in
community-based
agencies serving older
adults, as well as
Dr. Barry Rovner is Professor of Psychiatry and
Neurology and Director of Clinical Alzheimer’s
Disease Research of the Farber Institute for
Neurosciences. The focus of his research is to
test novel interventions to improve cognition,
prevent depression and enhance quality of life
for older adults.

Helping Caregivers to COPE

“Participating in research allows
families ...to get potentially
beneficial treatments for
their relatives before they are
available to the general public.”
Q: What do study participants gain
from being part of these research studies?
Dr. Rovner: We have learned that families
derive a lot of hope and support from
participating in these trials. In general,
participating in research allows families to
have the opportunity to get the best possible
care for their relatives, including potentially
beneficial treatments before they are available
to the general public. Being a participant
may lead to a decrease in the stress of

Did You Know?
As many as 80 percent of persons
with dementia are cared for in their
homes by family members.
caregiving, as well as provide the chance
to make a contribution to new scientific
knowledge. It is an opportunity to share
personal experiences so that others
may benefit.
Q: Are there any risks of participating in
drug trials?
Dr. Rovner: With trials of medications, there
are always some risks of side effects, however
we closely monitor any possible adverse
reactions. Drugs being studied have already
been tested before so that we can assure that
they are reasonably safe. ■
Contact information for Dr. Rovner
phone: 215-503-1254
fax:
215-503-1992
email: barry.rovner@jefferson.edu
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home to instruct her on practical methods
she could use to cope with her mother’s
progressive illness. She began by assessing
Margaret’s cognitive level as well as Deb’s
caregiving goals, understanding of the disease
and willingness to learn new strategies. She
found that Margaret had a high cognitive
level and was receiving unnecessary help
from her caring daughter. “Out of concern
and an unclear understanding of her mom’s
abilities, Deb was actually helping her mother
too much. Deb needed to learn more
about the disease and she was open to new
knowledge and adapting strategies to manage
better day-to-day,” says Vause-Earland.
Based on the assessments, Ms. Vause-Earland
designed an “action plan” for Deb to follow.
The plan included specific behavioral goals,
a summary of Margaret’s abilities or what
she could still do, and specific strategies for
Deb to implement to enhance her mother’s
participation in daily activities and decrease
her boredom and anxiety. Since Margaret
was once a housewife, Ms. Vause-Earland
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testing in-home skills training services to
delay nursing home placement and reduce
stress for a racially diverse group of family
caregivers. This latter study is being
conducted at the Center for Applied
Research on Aging and Health, by Principal
Investigator Laura N. Gitlin, PhD.

suggested activities such as washing dishes
or folding laundry — pain-free activities
that brought her satisfaction, a sense of
accomplishment, and reflected her previous
roles and interests. Ms. Vause-Earland also
helped to establish a nighttime routine for
Margaret: no coffee, taking a bath, playing
soothing music and using a nightlight. The
nightly routine prepared her for bed in a
relaxed manner and reduced her erratic
nighttime behavior.
Beyond these strategies, Ms. Vause-Earland
taught Deb how to build her own sense of
efficacy as a caregiver. Through stress-relieving
techniques and positive reinforcement,
Ms. Vause-Earland gave Deb confidence and
built her self-esteem. “Tracey taught me that
I didn’t need to do everything for Mom;
that it was okay to let go. She was the first
person to tell me that I was doing a good
job,” says Deb.
Ms. Vause-Earland saw Deb transform as a
result of her participation in Project COPE.
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“Deb’s energy and enthusiasm and readiness
to integrate new strategies into her daily
caregiving transformed her situation,”
asserts Vause-Earland. “By the end of her
participation in the study, she had much
more confidence in her abilities and a sense
of mastery. Deb now feels empowered,
more in control of her situation.”
Today, Deb is successfully coping with her
mother’s disease and both are much happier
as a result. “My mother now feels like she’s
part of the family, rather than looking in
from the outside. She’s happier now that
I’m letting her be her. She is what she is
today. You enjoy it and celebrate it. A
tremendous burden has been lifted off
of my shoulders.”
CARAH is still enrolling participants
for Project COPE. For more information
or to enroll in the study, please call
215-503-2897. ■
This article appeared in the July 18-31, 2007
edition of the City Suburban News.

